Shire

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.

All Articles

The UK enjoyed the highest value of M&A deals in Europe last year as telecoms and media takeovers spiked. High

February 19, 2019

Takeda has completed the takeover of London-listed Shire ahead of schedule after shareholders overwhelmingly backed the controversial $59bn (£46bn) deal

January 8, 2019

Takeda’s investors have approved the company’s $59bn (£46bn) takeover of Irish drugmaker Shire following months of wrangling with unhappy stakeholders.

December 5, 2018

Takeda Pharmaceutical will ask shareholders to vote on buying biotechnology firm Shire for $62bn (£48bn) on 5 December, it revealed

November 12, 2018

Irish drug giant Shire Pharma­ceuticals is prepared to top up its offer to woo rival Baxalta to the negotiating table

August 16, 2015

Shire's attempt to buy Baxalta could prove successful, so long as the pharmaceutical company agrees to add an extra $5bn

August 16, 2015

Shares in pharma giant Shire recovered this morning after its $30bn (£19bn) hostile bid to take over US biotech company

August 10, 2015

London-listed pharma giant Shire has made a hostile approach for US rival Baxalta. In a statement, the UK company offered $45.23

August 10, 2015

The board of Baxalta will come under renewed pressure to open takeover negotiations this week, following early campaigning by Shire

August 10, 2015
Immupharma shares take off as firm signs US lupus deal

ADHD drug-maker Shire is looking at a £12.4bn takeover of Europe’s biggest biotech company Actelion – just months after completing

June 7, 2015

Drugs giant Shire traded up to three per cent higher yesterday morning and closed 0.95 per cent up, after news

February 2, 2015

SHIRE’S $5.2bn (£3.45bn) takeover of NPS Pharmaceuticals just weeks ago is already paying off. Shire shares rose 1.08 per cent

January 26, 2015

Content tagged with "Shire"